Operating
Net gains (losses) on investments
Alnylam Pharmaceuticals Net gains (losses) on investments increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$956.00K to $0.00.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2014
Last reportedQ1 2026Apr 30, 2026
Metric ID:
gain_loss_on_investmentsHistorical Data
13 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.69M | -$31.16M | -$1.10M | -$7.85M | -$2.27M | -$16.84M | $78.00K | -$1.37M | -$1.57M | -$166.00K | -$956.00K | -$1.35M | $0.00 |
| QoQ Change | — | -266.7% | +96.5% | -615.6% | +71.1% | -643.0% | +100.5% | <-999% | -14.6% | +89.4% | -475.9% | -41.2% | +100.0% |
| YoY Change | — | — | — | -142.0% | +92.7% | -114.6% | +103.4% | — | +90.7% | — | <-999% | +1.2% | +100.0% |
Range-$31.16M – $18.69M
CAGR-100.0%
Avg YoY Growth-149.3%
Median YoY Growth+46.0%
Net gains (losses) on investments at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's net gains (losses) on investments?
- Alnylam Pharmaceuticals (ALNY) reported net gains (losses) on investments of $0.00 in Q1 2026.
- How has Alnylam Pharmaceuticals's net gains (losses) on investments changed year-over-year?
- Alnylam Pharmaceuticals's net gains (losses) on investments increased by 100.0% year-over-year, from -$956.00K to $0.00.